Company leadership to highlight strategic vision, AI-powered cardiovascular detection, and long-term growth opportunities
SAN FRANCISCO, Aug. 27, 2025 /PRNewswire/ -- Eko Health, a leader in AI-powered cardiac and pulmonary detection, today announced its participation in two upcoming investor conferences:
Connor Landgraf, Co-founder & Chief Executive Officer, and Justin Spencer, Chief Financial Officer, will represent Eko at both events. At the Baird Global Healthcare Conference, Landgraf and Spencer will participate in a fireside chat where they will discuss the company's strategic vision and long-term growth opportunities, highlight key milestones in advancing AI-powered cardiovascular detection, share insights on commercial traction with individual providers and health systems, and outline Eko's mission to make early detection of heart and lung disease more accessible worldwide.
The fireside chat is scheduled for Tuesday, September 9 at 9:40 a.m. ET and will be webcast live at here.
Conference participation is by invitation only. Investors interested in scheduling a meeting with Eko Health's management should contact their Baird or Morgan Stanley representative.
About Eko Health
Eko Health, Inc. is a digital health company advancing the detection and management of cardiovascular disease with AI-powered screening and monitoring solutions. Its FDA-cleared platform combines smart stethoscopes with machine learning algorithms to give clinicians earlier, more accurate insights at the point of care. Eko partners with health systems, payers, and providers to deliver scalable solutions that improve outcomes for patients worldwide.
For more information, visit www.ekohealth.com.
Media Contact:
Sam Moore
Eko Health
[email protected]
©2025 Eko Health, Inc. All rights reserved. SENSORA® is a registered trademark of Eko Health, Inc. MKT-0003934
SOURCE Eko Health
Share this article